Related Experiment Video
Updated: Jun 22, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Should diuretics always be included as initial antihypertensive management in early-stage CKD?
Julian Segura1, Luis M Ruilope
1Hypertension Unit, Nephrology Department, Hospital 12 de Octubre, Madrid 28041, Spain.
Insights
Combined antihypertensive therapy, including diuretics, is essential for managing hypertension in chronic kidney disease (CKD) patients. Diuretics effectively control volume overload and aid in achieving blood pressure goals for renal protection.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- Chronic kidney disease (CKD) presents significant cardiovascular risks, including hypertension driven by volume overload.
- Patients with CKD often exhibit micro/macroalbuminuria and multiple traditional and non-traditional risk factors.
- Hypertension in CKD is frequently multifactorial, necessitating comprehensive management strategies.
Purpose of the Study:
- To review the necessity of combined antihypertensive drug therapy in patients with CKD.
- To highlight the specific role and relevance of diuretics in managing hypertension in CKD.
- To emphasize the importance of achieving blood pressure goals for renal protection.
Main Methods:
- Literature review focusing on antihypertensive therapy in chronic kidney disease.
- Analysis of the role of diuretics in managing volume overload and hypertension.
- Evaluation of evidence supporting combined therapy for blood pressure control and proteinuria reduction.
Main Results:
- Combined antihypertensive therapy, frequently including diuretics, is typically required to reach blood pressure targets in CKD patients.
- Volume overload and extracellular volume expansion are key contributors to hypertension in CKD.
- Diuretics are instrumental in managing volume overload and achieving strict blood pressure control.
Conclusions:
- Strict blood pressure control and reduction of proteinuria are crucial for protecting against CKD progression.
- Diuretics remain a valuable tool for managing volume overload and achieving blood pressure goals in CKD.
- Despite other agents offering independent benefits, diuretics will continue to be a cornerstone of antihypertensive treatment in CKD.
Purpose Of Review:
This review focuses on the need for combined antihypertensive therapy drugs in patients with chronic kidney disease and the relevance of diuretics.
Recent Findings:
Chronic kidney disease is a high-risk situation characterized by the presence of volume overload-related hypertension, micro/macroalbuminuria and other traditional and nontraditional risk factors. To achieve the blood pressure goal in these patients, combined antihypertensive therapy (including diuretics) is usually required.
Summary:
Extracellular volume expansion is an important, if not the most important, contributing factor to hypertension seen in chronic kidney disease. Protection against progression of renal dysfunction has two main requirements: strict blood pressure control and lowering proteinuria to values as near to normal as possible. Diuretics have been a useful tool to manage volume overload and to achieve strict blood pressure control in patients with chronic kidney disease. Albeit other blood pressure-lowering agents offer additional favorable effects independently of blood pressure changes, diuretics will continue to be used in these patients.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Heart Failure Drugs: Diuretics
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Antihypertensive Drugs: Action of Diuretics
Acute Kidney Injury IV: Diagnostic Studies and Prevention